227
Views
22
CrossRef citations to date
0
Altmetric
Original Article

A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers

, , &
Pages 501-509 | Accepted 10 Jan 2006, Published online: 31 Jan 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Laura Meyer-Junco, Bradlee Rea, Kelly Mendoza & Jeffrey Fudin. (2022) Application Site Reactions from the Buprenorphine Transdermal Patch: A Case Series. Journal of Pain & Palliative Care Pharmacotherapy 36:1, pages 49-54.
Read now
Guy Hans & Dominique Robert. (2009) Transdermal buprenorphine – a critical appraisal of its role in pain management. Journal of Pain Research 2, pages 117-134.
Read now
Jhi-Joung Wang, Kuo-Sheng Liu, K. C. Sung, Chia-Yin Tsai & Jia-You Fang. (2009) Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. Journal of Microencapsulation 26:8, pages 734-747.
Read now

Articles from other publishers (19)

Christoph G. Dietrich, Tanja Kottmann, Hans Werner Voß & Roxane Lorenz. (2022) Aloe Vera-Containing Matrix in Transdermal Fentanyl Therapy Improves Adhesion, Skin Tolerance and Quality of Life: Results of a German Multicenter Study with a New Fentanyl Patch. Drug Research.
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 511 774 .
Thijs Defraeye, Flora Bahrami, Lu Ding, Riccardo Innocenti Malini, Alexandre Terrier & René M. Rossi. (2020) Predicting Transdermal Fentanyl Delivery Using Mechanistic Simulations for Tailored Therapy. Frontiers in Pharmacology 11.
Crossref
Stephen L. Thornton & Micheal A. Darracq. (2019) Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System. Journal of Medical Toxicology 16:1, pages 33-40.
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 447 696 .
Paul D Gavin, Lee S Simon, Thomas Schlagheck, Alisha J Smith & Janakan Krishnarajah. (2017) A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system. Pain Management 7:6, pages 499-512.
Crossref
Sven Stegemann. 2016. Developing Drug Products in an Aging Society. Developing Drug Products in an Aging Society 279 290 .
. 2015. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 417 651 .
Wojciech Leppert. (2013) A successful Switch From Transdermal Fentanyl to Transdermal Buprenorphine in a Patient with Neuropathic Pain. American Journal of Hospice and Palliative Medicine® 31:1, pages 101-104.
Crossref
Bethany Foster, Robert Twycross, Mary Mihalyo & Andrew Wilcock. (2013) Buprenorphine. Journal of Pain and Symptom Management 45:5, pages 939-949.
Crossref
Farzana Mitra, Shahead Chowdhury, Mike Shelley & Gary Williams. (2013) A Feasibility Study of Transdermal Buprenorphine Versus Transdermal Fentanyl in the Long-Term Management of Persistent Non-Cancer Pain. Pain Medicine 14:1, pages 75-83.
Crossref
Guy Hans. 2013. Handbook of Methadone Prescribing and Buprenorphine Therapy. Handbook of Methadone Prescribing and Buprenorphine Therapy 109 137 .
Robert F WolffKim Reid, Marcello di Nisio, Dagfinn Aune, Carla Truyers, Adrian V Hernandez, Kate Misso, Rob Riemsma & Jos Kleijnen. (2012) Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain. Pain Management 2:4, pages 351-362.
Crossref
Andrea Bershow & Erin Warshaw. (2011) Cutaneous Reactions to Transdermal Therapeutic Systems. Dermatitis 22:4, pages 193-203.
Crossref
Giorgio Attinà, Antonio Ruggiero, Palma Maurizi, Annalisa Arlotta, Antonio Chiaretti & Riccardo Riccardi. (2008) Transdermal buprenorphine in children with cancer‐related pain. Pediatric Blood & Cancer 52:1, pages 125-127.
Crossref
Kim Vander Hulst, Elisabeth Parera Amer, Claude Jacobs, Virginie Dewulf, Marie Baeck, Ramón M. Pujol Vallverdú, Ana Giménez‐Arnau, Dominique Tennstedt & An Goossens. (2008) Allergic contact dermatitis from transdermal buprenorphine. Contact Dermatitis 59:6, pages 366-369.
Crossref
Paul K. Kiptoo, Kalpana S. Paudel, Dana C. Hammell, Mohamed O. Hamad, Peter A. Crooks & Audra L. Stinchcomb. (2008) In vivo evaluation of a transdermal codrug of 6-?-naltrexol linked to hydroxybupropion in hairless guinea pigs. European Journal of Pharmaceutical Sciences 33:4-5, pages 371-379.
Crossref
Sheridan M Hoy & Gillian M Keating. (2008) Fentanyl Transdermal Matrix Patch (Durotep?? MT Patch; Durogesic?? DTrans??; Durogesic?? SMAT). Drugs 68:12, pages 1711-1721.
Crossref
Richard J. Bodnar. (2007) Endogenous opiates and behavior: 2006. Peptides 28:12, pages 2435-2513.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.